Mason Archival Repository Service

Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin

Show simple item record

dc.contributor.author Rodriguez, Carlos A.
dc.contributor.author Papanastasiou, Emilios A.
dc.contributor.author Juba, Melanie
dc.contributor.author Bishop, Barney
dc.date.accessioned 2015-10-12T17:24:51Z
dc.date.available 2015-10-12T17:24:51Z
dc.date.issued 2014-09-18
dc.identifier.citation Rodriguez CA, Papanastasiou EA, Juba M and Bishop B (2014) Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin. Front. Chem. 2:71. doi: 10.3389/fchem.2014.00071 en_US
dc.identifier.uri https://hdl.handle.net/1920/9938
dc.description.abstract The rampant spread of antibiotic resistant bacteria has spurred interest in alternative strategies for developing next-generation antibacterial therapies. As such, there has been growing interest in cationic antimicrobial peptides (CAMPs) and their therapeutic applications. Modification of CAMPs via conjugation to auxiliary compounds, including small molecule drugs, is a new approach to developing effective, broad-spectrum antibacterial agents with novel physicochemical properties and versatile antibacterial mechanisms. Here, we've explored design parameters for engineering CAMPs conjugated to small molecules with favorable physicochemical and antibacterial properties by covalently affixing a fluoroquinolone antibiotic, levofloxacin, to the ten-residue CAMP Pep-4. Relative to the unmodified Pep-4, the conjugate was found to demonstrate substantially increased antibacterial potency under high salt concentrations. Historically, it has been observed that most CAMPs lose antibacterial effectiveness in such high ionic strength environments, a fact that has presented a challenge to their development as therapeutics. Physicochemical studies revealed that P4LC was more hydrophobic than Pep-4, while mechanistic findings indicated that the conjugate was more effective at disrupting bacterial membrane integrity. Although the inherent antibacterial effect of the incorporated levofloxacin molecules did not appear to be substantially realized in this conjugate, these findings nevertheless suggest that covalent attachment of small molecule antibiotics with favorable physicochemical properties to CAMPs could be a promising strategy for enhancing peptide performance and overall therapeutic potential. These results have broader applicability to the development of future CAMP-antibiotic conjugates for potential therapeutic applications.
dc.description.sponsorship This work was supported by funds provided by the College of Science and the Department of Chemistry and Biochemistry at George Mason University. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. en_US
dc.language.iso en_US en_US
dc.publisher Frontiers Media en_US
dc.rights Attribution 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by/3.0/us/ *
dc.subject cationic antimicrobial peptide en_US
dc.subject peptide conjugate en_US
dc.subject antibiotics en_US
dc.subject peptide modification en_US
dc.subject levofloxacin en_US
dc.title Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin en_US
dc.type Article en_US
dc.identifier.doi http://dx.doi.org/10.3389/fchem.2014.00071


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States Except where otherwise noted, this item's license is described as Attribution 3.0 United States

Search MARS


Browse

My Account

Statistics